Alliance A071601: Phase II trial of BRAF/MEK inhibition in newly diagnosed papillary craniopharyngiomas
- Citation:
- J Clin Oncol vol 39 (no. 15_suppl) 2000
- Meeting Instance:
- ASCO 2021
- Year:
- 2021
- Type:
- Abstract
- Sub type:
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 3802
- Pharmas:
- Genentech
- Grants:
- U10CA180821, U10CA180882, U24CA196171, U10CA180868 (NRG)
- Corr. Author:
- Authors:
- Priscilla K. Brastianos Erin Twohy Susan Geyer Elizabeth R. Gerstner Timothy J. Kaufmann Michael W. Ruff Daniela Bota David Reardon Adam Cohen Macarena De La Fuente Glenn Lesser Jian Campian PK Agarwalla Priya Kumthekar Daniel P. Cahill Helen A. Shih Paul D. Brown Sandro Santagata Frederick G. Barker II Evanthia Galanis
- Networks:
- CA088, FL028, LAPS-IL036, LAPS-MA036, LAPS-MN026, NC002, VA002
- Study
- Alliance-A071601
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: